The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Xiaochuan WangKhalid Iqbal

Abstract

Development of rational therapeutic treatments of Alzheimer disease (AD) requires the elucidation of the etiopathogenic mechanisms of neurofibrillary degeneration and β-amyloidosis, the two hallmarks of this disease. Here we show, employing an adeno-associated virus serotype 1 (AAV1)-induced expression of the C-terminal fragment (I(2CTF)) of I(2)(PP2A), also called SET, in rat brain, decrease in protein phosphatase 2A (PP2A) activity, abnormal hyperphosphorylation of tau, and neurodegeneration; littermates treated identically but with vector only, i.e., AAV1-enhanced green fluorescent protein (GFP), served as a control. Furthermore, there was an increase in the level of activated glycogen synthase kinase-3β and enhanced expression of intraneuronal Aβ in AAV1-I(2CTF) animals. Morris water maze behavioral test revealed that infection with AAV1-I(2CTF) induced spatial reference memory and memory consolidation deficits and a decrease in the brain level of pSer133-CREB. These findings suggest a novel etiopathogenic mechanism of AD, which is initiated by the cleavage of I(2)(PP2A), producing I(2CTF), and describe a novel disease-relevant nontransgenic animal model of AD.

References

Jan 1, 1976·Analytical Biochemistry·A Bensadoun, D Weinstein
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G L CaporasoP Greengard
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K S KosikD J Selkoe
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Oct 1, 1985·The Journal of Cell Biology·L I BinderL I Rebhun
Sep 1, 1993·Journal of Neurochemistry·C X GongK Iqbal
Apr 15, 1997·Biochemistry·T SuzukiY Kirino
Sep 28, 1999·Journal of Neuropathology and Experimental Neurology·J J PeiR F Cowburn
Nov 5, 2002·Methods : a Companion to Methods in Enzymology·Sergei ZolotukhinRichard O Snyder
Jan 31, 2003·Expert Opinion on Therapeutic Targets·Angel BarcoEric R Kandel
May 23, 2003·Nature·Christopher J PhielPeter S Klein
Mar 23, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lap HoGiulio Maria Pasinetti
May 28, 2005·The American Journal of Pathology·Hitoshi TanimukaiKhalid Iqbal
Jun 15, 2005·Annual Review of Biochemistry·Inder M Verma, Matthew D Weitzman
Oct 26, 2005·Annals of Neurology·Khalid IqbalInge Grundke-Iqbal
Nov 3, 2005·The European Journal of Neuroscience·Fei LiuCheng-Xin Gong
Jun 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alejandra del C AlonsoKhalid Iqbal
Nov 23, 2006·Neurochemical Research·Amitabha SenguptaKhalid Iqbal
Jan 24, 2007·The European Journal of Neuroscience·Jian-Zhi WangKhalid Iqbal

❮ Previous
Next ❯

Citations

Feb 3, 2009·Acta Neuropathologica·Khalid IqbalInge Grundke-Iqbal
Aug 8, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gong-Ping LiuJian-Zhi Wang
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Antonella CaccamoSalvatore Oddo
Oct 19, 2013·Acta Neuropathologica·Xiaochuan WangKhalid Iqbal
Jun 8, 2011·Future Medicinal Chemistry·Michael VoronkovJeffry B Stock
Aug 7, 2013·Pharmacology & Therapeutics·Margaret K KingEléonore Beurel
Jul 2, 2014·BMC Neuroscience·Stéphanie ChasseigneauxBernadette Allinquant
Jan 7, 2014·Expert Opinion on Therapeutic Targets·Khalid IqbalFei Liu
Jan 4, 2015·Expert Review of Neurotherapeutics·Miguel Medina, Jesús Avila
Sep 26, 2015·Cellular and Molecular Life Sciences : CMLS·Yunpeng HuangBing Zhou
Jul 19, 2014·Neurobiology of Aging·Gustavo Basurto-IslasKhalid Iqbal
Jan 15, 2014·Biochemical Pharmacology·Khalid IqbalCheng-Xin Gong
Feb 5, 2013·Neurobiology of Aging·Guang YuXiaochuan Wang
Aug 23, 2011·Biochimica Et Biophysica Acta·Julien GuergnonAlphonse Garcia
Jul 10, 2012·Ageing Research Reviews·Ludovic MartinFaraj Terro
Jan 28, 2014·Biochemical Pharmacology·Miguel Medina, Jesús Avila
Mar 22, 2014·Frontiers in Molecular Neuroscience·Jean-Marie Sontag, Estelle Sontag
Apr 27, 2016·Expert Opinion on Therapeutic Targets·Zhentao ZhangKeqiang Ye
Jun 29, 2016·Molecular Neurobiology·Yi FengWeihong Song
Aug 4, 2016·Immunotherapy·Francesco PanzaGiancarlo Logroscino
Jan 30, 2016·Expert Review of Neurotherapeutics·Davide SeripaFrancesco Panza
Nov 2, 2018·Current Alzheimer Research·Xing LiXiaochuan Wang
Jul 23, 2019·Medicinal Research Reviews·Lili ZhangRongbiao Pi
Jun 18, 2014·Molecular Neurobiology·Xiaozhu ZhangWeihong Song
Apr 3, 2015·The Journal of Biological Chemistry·Ephraim F TrakhtenbergJeffrey L Goldberg
Jun 5, 2018·Neural Regeneration Research·Hong-Bin LuoJun-Xu Li
May 4, 2013·The Journal of Biological Chemistry·Gustavo Basurto-IslasKhalid Iqbal
Apr 25, 2018·Journal of Alzheimer's Disease : JAD·Gustavo Basurto-IslasKhalid Iqbal
Sep 4, 2018·Frontiers in Molecular Neuroscience·Shalini S Rao, Paul Anthony Adlard
Jul 15, 2018·Acta Neuropathologica Communications·Mirta BorinSilvia Bolognin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.